142 related articles for article (PubMed ID: 37869482)
1. Ultrasound-Guided Collagenase Injection Therapy of Recurrent Plantar Fibromatosis: A Case Report.
Greenfield AL; Baez AB; Humbyrd CJ
Foot Ankle Orthop; 2023 Oct; 8(4):24730114231201161. PubMed ID: 37869482
[No Abstract] [Full Text] [Related]
2. The Effects of Collagenase Clostridium histolyticum on Plantar Fibromatosis: A Case Study.
Lehrman JD; Miceli ALL; Tabchi SG; Kaplan MA
J Foot Ankle Surg; 2019 Nov; 58(6):1281-1284. PubMed ID: 31679681
[TBL] [Abstract][Full Text] [Related]
3. Collagenase Clostridium histolyticum injection for plantar fibromatosis (Ledderhose disease).
Hammoudeh ZS
Plast Reconstr Surg; 2014 Sep; 134(3):497e-499e. PubMed ID: 25158740
[No Abstract] [Full Text] [Related]
4. OPTIMAL INJECTION DEPTH FOR COLLAGENASE CLOSTRIDIUM HISTOLYTICUM DETERMINED BY ULTRASONOGRAPHY IN THE TREATMENT OF DUPUYTREN´S DISEASE.
Nagura I; Kanatani T; Harada Y; Inui A; Mifune Y; Kuroda R; Lucchina S
Acta Chir Plast; 2020; 62(3-4):64-67. PubMed ID: 33685199
[TBL] [Abstract][Full Text] [Related]
5. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
[TBL] [Abstract][Full Text] [Related]
6. DIFFUSION OF INJECTED COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR DUPUYTREN´S DISEASE: AN IN-VIVO STUDY.
Kanatani T; Nagura I; Harada Y; Lucchina S
Acta Chir Plast; 2020; 62(3-4):60-63. PubMed ID: 33685198
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Dupuytren's disease after fasciectomy and collagenase injection are histologically indistinguishable.
Sanjuan-Cervero R; Carrera-Hueso FJ; Vaquero-Perez M; Montaner-Alonso D
J Hand Surg Eur Vol; 2020 Jun; 45(5):508-512. PubMed ID: 31980000
[TBL] [Abstract][Full Text] [Related]
8. Bilateral Plantar Fibromatosis.
Newman C; McQuaid SE
Ir Med J; 2019 Apr; 112(4):919. PubMed ID: 31243948
[TBL] [Abstract][Full Text] [Related]
9. Can collagenase effectiveness in Dupuytren's contracture be improved by using ultrasound-guided Injection? A comparative study.
Aguilella L; Pérez-Giner R; Higueras-Guerrero V; Belloch-Ramos E; Cuenca-Torres M; Juan EL
J Plast Surg Hand Surg; 2022 Feb; 56(1):23-29. PubMed ID: 33840343
[TBL] [Abstract][Full Text] [Related]
10. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
[TBL] [Abstract][Full Text] [Related]
11. Unusual Intranodular Collagenase Injection: A Case of Bilateral Ledderhose Disease.
De Vitis R; Passiatore M; Perna A; Starnoni M; Taccardo G
Plast Reconstr Surg Glob Open; 2020 Apr; 8(4):e2754. PubMed ID: 32440422
[TBL] [Abstract][Full Text] [Related]
12. Salvage palmar fasciectomy after initial treatment with collagenase clostridium histolyticum.
Eberlin KR; Kobraei EM; Nyame TT; Bloom JM; Upton J
Plast Reconstr Surg; 2015 Jun; 135(6):1000e-1006e. PubMed ID: 26017606
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
Badalamente MA; Hurst LC; Benhaim P; Cohen BM
J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
[TBL] [Abstract][Full Text] [Related]
14. Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.
Smeraglia F; Del Buono A; Maffulli N
Br Med Bull; 2016 Jun; 118(1):149-58. PubMed ID: 27151958
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
Goldstein I; Lipshultz LI; McLane M; Hu Y; Xiang Q; Liu G; Vijayan S; Gelbard MK
J Urol; 2020 Jun; 203(6):1191-1197. PubMed ID: 31922462
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
Gelbard M; Goldstein I; Hellstrom WJ; McMahon CG; Smith T; Tursi J; Jones N; Kaufman GJ; Carson CC
J Urol; 2013 Jul; 190(1):199-207. PubMed ID: 23376148
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Effects of the Collagenase of the Bacterium Clostridium histolyticum for the Treatment of Capsular Fibrosis After Silicone Implants.
Fischer S; Diehm Y; Henzler T; Berger MR; Kolbenschlag J; Latz A; Bueno EM; Hirche C; Kneser U; Pomahac B
Aesthetic Plast Surg; 2017 Feb; 41(1):211-220. PubMed ID: 28008464
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of clinical and sonographic features after extracorporeal shock wave therapy in painful plantar fibromatosis.
Hwang JT; Yoon KJ; Park CH; Choi JH; Park HJ; Park YS; Lee YT
PLoS One; 2020; 15(8):e0237447. PubMed ID: 32776988
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Ralph DJ; Abdel Raheem A; Liu G
J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
[TBL] [Abstract][Full Text] [Related]
20. Peyronie's disease response to intralesional collagenase clostridium histolyticum therapy is independent of baseline testosterone.
Schneider D; O'Leary M; Amini E; Miller J; Hassas N; Nguyen J; Hammad MAM; Barham D; Yafi FA
Andrology; 2024 May; 12(4):830-834. PubMed ID: 37753943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
